Performance of interferon-γ release assay for the diagnosis of active or latent tuberculosis in children in the first 2 years of age: A multicenter study of the Italian society of pediatric infectious diseases

Pediatric Infectious Disease Journal

Volumn 33, Issue 9, 2014, Pages E226-E231

  Garazzino, Silvia ^a   Galli, Luisa ^b   Chiappini, Elena ^b   Pinon, Michele ^a   Bergamini, Barbara Maria ^c   Cazzato, Salvatore ^d   Dal Monte, Paola ^e   Dodi, Icilio ^f   Lancella, Laura ^g   Esposito, Susanna ^h   Iughetti, Lorenzo ^c   Montagnani, Carlotta ^b   De Martino, Maurizio ^b   Tovo, Pier Angelo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f Pietro Barilla Children's Hospital   (Italy)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

Children; Infants; Interferon release assay; QuantiFERON; Tuberculin skin testing; Tuberculosis

Indexed keywords

BCG VACCINE;

ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; IMMUNOLOGY; INFANT; INTERFERON GAMMA RELEASE ASSAY; ITALY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTICENTER STUDY; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS TEST KIT; NEWBORN; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

BCG VACCINE; CHILD, PRESCHOOL; DIAGNOSIS; FEMALE; HUMANS; IMMUNOLOGY; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA RELEASE TESTS; ITALY; LATENT TUBERCULOSIS; MALE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 84965125711     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000353     Document Type: Article

References (36)

1. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012;367:348-361.
2. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva, Switzerland: World Health Organization; 2006. WHO/HTM/TB/2006.371. Available at: http://whqlibdoc.who.int/hq/2006/WHO-HTM-TB-2006.371-eng.pdf. Accessed February 4, 2014.
3. Zar HJ, Hanslo D, Apolles P, et al. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet. 2005;365:130-134.
4. Marais BJ, Hesseling AC, Gie R P, et al. The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis. 2006;42:e69-e71.
5. Menzies RI. Tubercolin skin testing. In: Reichman LB, Herschfield ES, eds. Tuberculosis: A Comprehensive International Approach. 2nd ed. New York, NY: Marcel Dekker; 2000:279-322.
6. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968-975.
7. Piñeiro R, Mellado MJ, Cilleruelo MJ, et al. Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr. 2012;171:1625-1632.
8. Dheda K, van Zyl Smit R, Badri M, et al. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in highburden vs.low-burden settings. Curr Opin Pulm Med. 2009;15:188-200.
9. Marais BJ, Pai M. Recent advances in the diagnosis of childhood tuberculosis. Arch Dis Child. 2007;92:446-452.
10. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn. 2006;6:413-422.
11. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354.
12. Diel R, Loddenkemper R, Meywald-Walter K, et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177:1164-1170.
13. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008;149:777-787.
14. Mazurek GH, Jereb J, Vernon A, et al.; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1-25.
15. Bamford AR, Crook AM, Clark JE, et al. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child. 2010;95:180-186.
16. Diel R, Goletti D, Ferrara G, et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88-99.
17. Kakkar F, Allen U, Ling D, et al. Tuberculosis in children: new diagnostic blood tests. Paediatr Child Health. 2010;15:529-538.
18. Haustein T, Ridout DA, Hartley JC, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28:669-673.
19. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet. 2006;367:1328-1334.
20. Pavić I, Topić RZ, Raos M, et al. Interferon-γ release assay for the diagnosis of latent tuberculosis in children younger than 5 years of age. Pediatr Infect Dis J. 2011;30:866-870.
21. Chiappini E, Bonsignori F, Accetta G, et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review. Int J Immunopathol Pharmacol. 2012;25:335-343.
22. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, Baker CJ, Long SS, et al., eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:678-698.
23. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva, Switzerland: World Health Organization; 2006. WHO/HTM/TB/2006.371. Available at: http://whqlibdoc.who.int/hq/2006/WHO-HTM-TB-2006.371-eng.pdf. Accessed February 4, 2014.
24. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J. 2011;30:694-700.
25. Mandalakas AM, Detjen AK, Hesseling AC, et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2011;15:1018-1032.
26. Sun L, Xiao J, Miao Q, et al. Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis. FEMS Immunol Med Microbiol. 2011;63:165-173.
27. Critselis E, Amanatidou V, Syridou G, et al. The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection. J Pediatr. 2012;161:632-638.
28. Banfield S, Pascoe E, Thambiran A, et al. Factors associated with the performance of a blood-based interferon-γ release assay in diagnosing tuberculosis. PLoS One. 2012;7:e38556.
29. Basu Roy R, Sotgiu G, Altet-Gómez N, et al. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. Am J Respir Crit Care Med. 2012;186:378-384.
30. Ling DI, Zwerling AA, Steingart KR, et al. Immune-based diagnostics for TB in children: what is the evidence? Paediatr Respir Rev. 2011;12:9-15.
31. Thomas TA, Mondal D, Noor Z, et al. Pediatrics. 2010;126:e1522-e1529.
32. World Health Organization. Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement. Geneva, Switzerland: World Health Organization; 2006. WHO/HTM/TB/2006.371. Available at: http://whqlibdoc.who.int/hq/2006/WHO-HTM-TB-2006.371-eng.pdf. Accessed February 4, 2014.
33. Update guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Reccom Rep. 2010;59(RR-5):1-25.
34. Debord C, De Lauzanne A, Gourgouillon N, et al. Interferon-gamma release assay performance for diagnosing tuberculosis disease in 0- to 5-year-old children. Pediatr Infect Dis J. 2011;30:995-997.
35. Méndez-Echevarría A, González-Muñoz M, Mellado MJ, et al.; Spanish Collaborative Group for Study of QuantiFERON-TB GOLD Test in Children. Interferon-γ release assay for the diagnosis of tuberculosis in children. Arch Dis Child. 2012;97:514-516.
36. Méndez-Echevarría A, González-Muñoz M, Mellado MJ, et al.; Spanish Collaborative Group for the Study of QuantiFERON-TB GOLD Test in Children. Optimizing interpretation of the tuberculin test using an interferon-gamma release assay as a reference standard. Pediatr Infect Dis J. 2011;30:426-428.